NMDA receptor associated_with schizophrenia
Evidence from:
primary |
all sources
Evidence (2 sources)
Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study.
(2015)
PMID:25784808
cited
enhancing the NMDA receptor activity according to the hypo‑NMDA receptor hypothesis of that psychosis
confidence: 0.80
Glutamatergic transmission in schizophrenia: from basic research to clinical practice.
(2012)
PMID:22297716
cited
dysfunction of the brain glutamate system ... as a fundamental underlying pathophysiology in schizophrenia
confidence: 0.94